GPI and cancer: Previous attempts to knock-down GPI in the LS174T cancer cell line with doxycycline-inducible short hairpin (sh) RNA showed that 90% silencing of GPI enzymatic activity did not change the rate of glycolysis, indicating the limits of shRNA use for non-limiting enzymes (Laferrière J. and Pouyssegur J. unpublished results).